1-2 of 2
Alison Goudie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

Clinical Trials & Observations
Bob Löwenberg, Petra Muus, Gert Ossenkoppele, Philippe Rousselot, Jean-Yves Cahn, Norbert Ifrah, Giovanni Martinelli, Sergio Amadori, Ellin Berman, Pieter Sonneveld, Mojca Jongen-Lavrencic, Sophie Rigaudeau, Paul Stockman, Alison Goudie, Stefan Faderl, Elias Jabbour, Hagop Kantarjian
Journal: Blood
Blood (2011) 118 (23): 6030–6036.
https://doi.org/10.1182/blood-2011-07-366930
Published: 2011
Journal Articles

Phase I/II Study to Assess the Safety and Efficacy of the Aurora B Kinase Inhibitor, AZD1152, in Patients with Advanced Acute Myeloid Leukemia.

Bob Lowenberg, MD, PhD, Philippe Rousselot, MD, PhD, Giovanni Martinelli, MD, Alison Goudie, Paul Stockman, Hagop Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 2080.
https://doi.org/10.1182/blood.V114.22.2080.2080
Published: 2009